In addition, we found that matrine impairs the growth of KRAS‐mutant PDAC, but not KRAS‐wt PDAC; therefore, these observations indicate that matrine can be an appropriate therapeutic reagent for KRAS‐driven cancers with high basal levels of autophagy. The gene discussed is KRAS; the disease is cancer.